ORIC PHARMACEUTICALS

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 10 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

20 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

30 8 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

10 8 2023 15:05:03 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 8 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces $85 Million Private Placement Financing

26 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 6 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference

31 5 2023 15:10:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates

08 5 2023 15:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 5 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 4 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 4 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

14 3 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

06 3 2023 15:15:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 2 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 2 2023 15:30:00 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones

09 1 2023 07:00:01 提供 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 15:30:00 提供 Nasdaq GlobeNewswire